Evidence map›Paper›PMID 26895430›Full record

ArticleImmunologic research2016

Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.

Inna Tabansky, Mark D Messina, Catherine Bangeranye, Jeffrey Goldstein, Karen M Blitz-Shabbir, Suly Machado, Venkatesh Jeganathan, Paul Wright, Souhel Najjar, Yonghao Cao and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Immunologic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Inna TabanskyDepartment of Neurobiology and Behavior, The Rockefeller University, New York, NY, USA.
Mark D MessinaDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Catherine BangeranyeDepartment of Science Education, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Jeffrey GoldsteinDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Karen M Blitz-ShabbirDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Suly MachadoDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Venkatesh JeganathanDepartment of Autoimmunity, The Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY, USA.
Paul WrightDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Souhel NajjarDepartment of Neurology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Yonghao CaoDepartment of Autoimmunity, The Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY, USA.
Warren SandsSchool of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Derin B KeskinDepartment of Cancer Immunology and AIDS, Dana Farber-Harvard Cancer Institute, Boston, MA, USA.
Joel N H SternDepartment of Neurobiology and Behavior, The Rockefeller University, New York, NY, USA. jstern01@rockefeller.edu.
Hofstra University · USFeinstein Institute for Medical Research · USDana-Farber Cancer Institute · USRockefeller University · USUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26895430
OpenAlexW2280549938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.